Joshua J. Ofman Sells 9,692 Shares of GRAIL, Inc. (NASDAQ:GRAL) Stock

GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) President Joshua J. Ofman sold 9,692 shares of the company's stock in a transaction that occurred on Monday, June 30th. The stock was sold at an average price of $52.00, for a total value of $503,984.00. Following the transaction, the president owned 492,076 shares in the company, valued at $25,587,952. This trade represents a 1.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

GRAIL Stock Down 4.3%

Shares of GRAL stock traded down $2.19 during trading hours on Tuesday, hitting $49.23. 1,451,172 shares of the company's stock traded hands, compared to its average volume of 1,203,456. The stock's fifty day simple moving average is $39.75 and its two-hundred day simple moving average is $32.17. GRAIL, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99. The stock has a market cap of $1.77 billion and a price-to-earnings ratio of -0.81.

GRAIL (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($3.10) earnings per share for the quarter, beating analysts' consensus estimates of ($4.03) by $0.93. The company had revenue of $31.84 million during the quarter, compared to analyst estimates of $35.80 million. GRAIL had a negative return on equity of 17.99% and a negative net margin of 1,464.53%. On average, equities analysts forecast that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

Institutional Trading of GRAIL

A number of institutional investors and hedge funds have recently bought and sold shares of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of GRAIL by 37.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 92,465 shares of the company's stock worth $2,362,000 after buying an additional 25,177 shares in the last quarter. Scientech Research LLC bought a new position in GRAIL in the 1st quarter valued at approximately $644,000. NewEdge Advisors LLC lifted its position in GRAIL by 390.3% in the 1st quarter. NewEdge Advisors LLC now owns 1,760 shares of the company's stock valued at $45,000 after acquiring an additional 1,401 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in GRAIL by 28.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,835 shares of the company's stock valued at $76,000 after purchasing an additional 623 shares during the last quarter. Finally, AQR Capital Management LLC increased its holdings in shares of GRAIL by 61.0% in the 1st quarter. AQR Capital Management LLC now owns 1,337,163 shares of the company's stock worth $33,991,000 after purchasing an additional 506,440 shares in the last quarter.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Canaccord Genuity Group lifted their price target on GRAIL from $32.00 to $43.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Morgan Stanley boosted their target price on shares of GRAIL from $16.00 to $20.00 and gave the company an "equal weight" rating in a report on Tuesday, March 18th.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.